Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.

MLA

Nerurkar PV, et al. “Momordica Charantia (Bitter Melon) Reduces Plasma Apolipoprotein B-100 and Increases Hepatic Insulin Receptor Substrate and Phosphoinositide-3 Kinase Interactions.” British Journal of Nutrition, vol. 100, no. 4, Oct. 2008, pp. 751–59. EBSCOhost, https://doi.org/10.1017/s0007114508937430.

APA

Nerurkar PV, Lee YK, Motosue M, Adeli K, & Nerurkar VR. (2008). Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. British Journal of Nutrition, 100(4), 751–759. https://doi.org/10.1017/s0007114508937430

Chicago

Nerurkar PV, Lee YK, Motosue M, Adeli K, and Nerurkar VR. 2008. “Momordica Charantia (Bitter Melon) Reduces Plasma Apolipoprotein B-100 and Increases Hepatic Insulin Receptor Substrate and Phosphoinositide-3 Kinase Interactions.” British Journal of Nutrition 100 (4): 751–59. doi:10.1017/s0007114508937430.